Clinical Trials
The Department of Psychiatry & Behavioral Sciences invites research subjects to participate in studies aimed at improving the diagnosis and treatment of schizophrenia, psychosis (e.g., hearing voices, paranoia), bipolar disorder, depression, and anxiety.
Our clinical trial team consists of skilled psychiatrists and research coordinators who will carefully monitor subjects during their participation. Browse the active studies below or call our Clinical Research Program office at 312-503-7071.
Feinberg Clinical Trials
Scientists at the medical school are conducting hundreds of clinical trials daily. Learn more about all our work via the Feinberg Office of Research Clinical Trials page. Search for trials by disease or condition.
| Trials |
|---|
Northwestern University The Department of Psychiatry and Behavioral Sciences, Clinical Research Program (NU CRP) Recruitment PipelineThe recruitment pipeline provides research staff with an organized system of identifying researchsubjects.NU CRP clinical research studies covers a wide spectrum of Axis I Diagnoses such as schizophrenia, depression, anxiety, etc. NU CRP also conducts research studies for patients who are diagnosed with certain neurological diseases such as Alzheimer’… The recruitment pipeline provides research staff with an organized system of identifying researchsubjects.NU CRP clinical research studies covers a wide spectrum of Axis I Diagnoses such as schizophrenia, depression, anxiety, etc. NU CRP also conducts research studies for patients who are diagnosed with certain neurological diseases such as Alzheimer’s disease, Tourette’s Syndrome, etc. NU CRP conducts basic, translational and clinical research. Personal Health Information (PHI) will not be collected. All information collected in this recruitmentregistry is based on the patient self-report. You will be contacted to answer additional questions by someone in the study staff and to determine your eligibility for the current studies. Copy Study URL to Clipboard Copy |
The CLICK Study- a digital mental health app for adults with schizophreniaWhat is this study about? The purpose of this study is to evaluate a digital mental health application for adults with schizophrenia who are experiencing social withdrawal, reduced emotions and decreased motivation. This application will be added to the current antipsychotic therapy treatment.What will I do if I participate? … What is this study about? The purpose of this study is to evaluate a digital mental health application for adults with schizophrenia who are experiencing social withdrawal, reduced emotions and decreased motivation. This application will be added to the current antipsychotic therapy treatment. What will I do if I participate? Participants will take part in 4 study visits in-person at Northwestern Hospital and 3 remote visits over the course of 4 months. Visits will include clinical assessments and questionnaires regarding mental health symptoms. In addition, participants will use the digital application daily for 5-30 minutes. Copy Study URL to Clipboard Copy |
The OARS-7 Study for Major Depressive DisorderThe purpose of the J&J OARS-7 Study is to evaluate a medication to treat depression (MDD) and depression with insomnia (MDDIS). This study is for intended for people diagnosed with depression who have only experienced a partial response to their current antidepressant treatment; in other words, they … The purpose of the J&J OARS-7 Study is to evaluate a medication to treat depression (MDD) and depression with insomnia (MDDIS). This study is for intended for people diagnosed with depression who have only experienced a partial response to their current antidepressant treatment; in other words, they are still currently experiencing symptoms of depression. The main goal of this study is to learn how safe the study drug is and how well the study drug works when taken with the antidepressants you are currently taking for depression. What will I do if I participate? There are two parts of this study. In part 1, participants will take part in 8 study visits in-person at Northwestern Hospital where they will be given either study drug or a placebo. After part one, participants may be offered the option to continue into part 2, which is an open-label phase (everyone receives study drug). Visits will include clinical assessments and questionnaires regarding mental health symptoms. Copy Study URL to Clipboard Copy |